|
2017 |
Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke. |
Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Sonogashira diversification of unprotected halotryptophans, halotryptophan containing tripeptides; and generation of a new to nature bromo-natural product and its diversification in water |
Christopher Cartmell |
|
2017 |
Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain. |
John M. Streicher, PhD |
|
2017 |
Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy. |
Nam Lee, Ph.D. |
|
2017 |
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Blocking CRMP2 SUMOylation reverses neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. |
John M. Streicher, PhD |
|
2017 |
Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. |
Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Remote Ischemic Conditioning Preserves Cognition and Motor Coordination in a Mouse Model of Traumatic Brain Injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism. |
Nam Lee, Ph.D. |
|
2017 |
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Long-lasting antinociceptive effects of green light in acute and chronic pain in rats. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, T. Philip Malan, PhD, MD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2017 |
Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. |
Frank Porreca, PhD |
|
2017 |
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. |
John M. Streicher, PhD |
|
2018 |
Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery. |
Thomas P Davis, PhD, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications. |
John M. Streicher, PhD |
|
2018 |
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. |
Patrick T Ronaldson, PhD, FAAPS |
|
2018 |
Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer that Reduces Morphine Withdrawal in Mice. |
John M. Streicher, PhD |
